Rentokil Historical Income Statement

RTO Stock  USD 23.86  0.15  0.62%   
Historical analysis of Rentokil Initial income statement accounts such as Other Operating Expenses of 5.7 B, Operating Income of 754.7 M, EBIT of 823.5 M or Ebitda of 1.4 B can show how well Rentokil Initial PLC performed in making a profits. Evaluating Rentokil Initial income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Rentokil Initial's future profits or losses.
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Rentokil Initial PLC latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Rentokil Initial PLC is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rentokil Initial PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Rentokil Income Statement Analysis

Rentokil Initial PLC Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Rentokil Initial shareholders. The income statement also shows Rentokil investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Rentokil Initial Income Statement Chart

At this time, Rentokil Initial's EBIT is very stable compared to the past year. As of the 18th of January 2025, EBITDA is likely to grow to about 1.4 B, though Total Other Income Expense Net is likely to grow to (112.9 M).

Total Revenue

Total revenue comprises all receipts Rentokil Initial PLC generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Rentokil Initial PLC minus its cost of goods sold. It is profit before Rentokil Initial operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Rentokil Initial PLC. It is also known as Rentokil Initial overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Rentokil Initial's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Rentokil Initial PLC current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rentokil Initial PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
At this time, Rentokil Initial's EBIT is very stable compared to the past year. As of the 18th of January 2025, EBITDA is likely to grow to about 1.4 B, though Total Other Income Expense Net is likely to grow to (112.9 M).
 2022 2023 2024 2025 (projected)
Interest Expense74M189M217.4M228.2M
Depreciation And Amortization386M475M546.3M573.6M

Rentokil Initial income statement Correlations

0.760.940.740.940.780.850.940.680.54-0.20.460.860.090.670.56-0.650.81-0.38-0.780.780.8
0.760.910.90.910.850.930.90.860.6-0.260.50.91-0.110.660.42-0.760.86-0.08-0.920.630.78
0.940.910.850.990.920.970.990.780.66-0.220.570.940.030.780.63-0.740.85-0.33-0.890.770.85
0.740.90.850.850.690.850.840.990.49-0.260.40.76-0.420.570.27-0.730.730.11-0.850.390.6
0.940.910.990.850.890.950.980.80.57-0.320.480.920.020.760.6-0.740.82-0.33-0.890.760.84
0.780.850.920.690.890.960.920.60.76-0.160.690.940.180.880.77-0.690.8-0.4-0.860.790.85
0.850.930.970.850.950.960.980.780.73-0.20.650.960.010.850.66-0.770.86-0.3-0.920.740.84
0.940.90.990.840.980.920.980.770.68-0.20.60.960.040.810.65-0.750.87-0.34-0.90.780.86
0.680.860.780.990.80.60.780.770.36-0.350.260.69-0.490.480.16-0.70.650.17-0.80.30.53
0.540.60.660.490.570.760.730.680.360.50.990.730.120.70.61-0.510.72-0.27-0.620.60.61
-0.2-0.26-0.22-0.26-0.32-0.16-0.2-0.2-0.350.50.57-0.150.1-0.13-0.060.170.020.10.23-0.11-0.18
0.460.50.570.40.480.690.650.60.260.990.570.640.130.670.6-0.430.63-0.28-0.520.540.54
0.860.910.940.760.920.940.960.960.690.73-0.150.640.160.820.64-0.750.94-0.34-0.920.830.89
0.09-0.110.03-0.420.020.180.010.04-0.490.120.10.130.160.240.390.010.17-0.64-0.020.530.32
0.670.660.780.570.760.880.850.810.480.7-0.130.670.820.240.86-0.640.68-0.47-0.750.730.75
0.560.420.630.270.60.770.660.650.160.61-0.060.60.640.390.86-0.250.46-0.56-0.540.770.74
-0.65-0.76-0.74-0.73-0.74-0.69-0.77-0.75-0.7-0.510.17-0.43-0.750.01-0.64-0.25-0.730.220.66-0.41-0.48
0.810.860.850.730.820.80.860.870.650.720.020.630.940.170.680.46-0.73-0.19-0.880.770.83
-0.38-0.08-0.330.11-0.33-0.4-0.3-0.340.17-0.270.1-0.28-0.34-0.64-0.47-0.560.22-0.190.08-0.63-0.35
-0.78-0.92-0.89-0.85-0.89-0.86-0.92-0.9-0.8-0.620.23-0.52-0.92-0.02-0.75-0.540.66-0.880.08-0.72-0.87
0.780.630.770.390.760.790.740.780.30.6-0.110.540.830.530.730.77-0.410.77-0.63-0.720.93
0.80.780.850.60.840.850.840.860.530.61-0.180.540.890.320.750.74-0.480.83-0.35-0.870.93
Click cells to compare fundamentals

Rentokil Initial Account Relationship Matchups

Rentokil Initial income statement Accounts

202020212022202320242025 (projected)
Depreciation And Amortization324.7M326.5M386M475M546.3M573.6M
Interest Expense40.3M33.3M74M189M217.4M228.2M
Total Revenue2.8B3.0B3.7B5.4B6.2B6.5B
Gross Profit653M714.8M977M4.4B5.1B5.4B
Other Operating Expenses2.5B2.6B3.2B4.8B5.5B5.7B
Operating Income301M366.2M498M625M718.8M754.7M
Ebit256.3M329.5M381M682M784.3M823.5M
Ebitda581M656M767M1.2B1.3B1.4B
Total Operating Expenses352M348.6M479M3.8B4.4B4.6B
Income Before Tax221.5M317M287M493M567.0M595.3M
Total Other Income Expense Net(64M)(22M)(21M)(132M)(118.8M)(112.9M)
Net Income186M263M232M381M438.2M460.1M
Income Tax Expense43.5M61.9M64M112M128.8M135.2M
Cost Of Revenue2.1B2.2B2.7B927M834.3M1.1B
Selling General Administrative1.3B1.3B1.4B1.7B2.0B1.1B
Tax Provision43.5M61.9M64M112M128.8M135.2M
Interest Income10.2M1M21M25M22.5M14.1M
Net Income Applicable To Common Shares283.8M186.3M263.2M232M208.8M196.3M
Net Interest Income(34.7M)(32.6M)(72M)(164M)(147.6M)(140.2M)
Net Income From Continuing Ops186.3M263.2M232M381M438.2M228.8M
Reconciled Depreciation311.3M297.9M364M475M546.3M359.7M

Pair Trading with Rentokil Initial

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Rentokil Initial position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rentokil Initial will appreciate offsetting losses from the drop in the long position's value.

Moving against Rentokil Stock

  0.51MG Mistras GroupPairCorr
  0.41VCIG VCI Global LimitedPairCorr
The ability to find closely correlated positions to Rentokil Initial could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rentokil Initial when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rentokil Initial - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rentokil Initial PLC to buy it.
The correlation of Rentokil Initial is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rentokil Initial moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rentokil Initial PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Rentokil Initial can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Rentokil Initial PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rentokil Initial's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rentokil Initial Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rentokil Initial Plc Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rentokil Initial PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Environmental & Facilities Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rentokil Initial. If investors know Rentokil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rentokil Initial listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.06
Dividend Share
0.091
Earnings Share
0.95
Revenue Per Share
10.735
Quarterly Revenue Growth
0.013
The market value of Rentokil Initial PLC is measured differently than its book value, which is the value of Rentokil that is recorded on the company's balance sheet. Investors also form their own opinion of Rentokil Initial's value that differs from its market value or its book value, called intrinsic value, which is Rentokil Initial's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rentokil Initial's market value can be influenced by many factors that don't directly affect Rentokil Initial's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rentokil Initial's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rentokil Initial is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rentokil Initial's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.